ClinicalTrials.Veeva

Menu

Prospective RCT Lidocaine & Levobupivacaine on Block Dynamics After Subparaneural Popliteal Sciatic Nerve Block

The Chinese University of Hong Kong logo

The Chinese University of Hong Kong

Status and phase

Enrolling
Phase 4

Conditions

Musculoskeletal Diseases or Conditions

Treatments

Drug: 0.5% Levobupivacaine
Drug: 2% Xylocaine with adrenaline 1:200,000

Study type

Interventional

Funder types

Other

Identifiers

NCT04397484
2020.127-T

Details and patient eligibility

About

Sciatic nerve block at the popliteal fossa is indicated for foot or ankle surgery, and the introduction of ultrasound guidance (USG) has improved the ease and accuracy of the performance of this block. Recent studies proved that subparaneural injection is associated with faster block onset, higher block success rate, and prolonged block duration suggesting subparaneural compartment of the sciatic nerve is a desirable site for local anaesthetic injection. Data from an ongoing trial in the investigator's institution comparing the block dynamics of subparaneural injection of 30ml 0.5% levobupivacaine (Chirocaine) above and below the bifurcation of the sciatic nerve at popliteal fossa has also shown that the time to 'readiness for surgery' was faster when the injection was performed below the bifurcation of the sciatic nerve. Lidocaine (Xylocaine) has a better pharmacokinetic and pharmacodynamics profile than levobupivacaine and is also widely used as local anaesthetic agent in clinical practice. Since there is no data comparing the block dynamics of lidocaine and levobupivacaine, this study aims to study and compare the block dynamics of lidocaine and levobupivacaine when given as a subparaneural injection below the bifurcation of the sciatic nerve at the popliteal fossa. In this study, the investigator hypothesizes that the use of lidocaine as the sole agent for this block will fasten the time to 'readiness for surgery' as compared to levobupivacaine when given as a subparaneural injection below the bifurcation of the sciatic nerve at the popliteal fossa.

Full description

This study will involve performing ultrasound guided subparaneural popliteal sciatic nerve block for 40 patients by using either Lidocaine or Levobupivacaine. Both are commonly used local anaesthetics for regional anaesthesia in daily clinical practice. Patients will be enrolled from the elective orthopaedic surgical list at Prince of Wales Hospital after informed consent.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • American Society of Anesthesiologists (ASA) physical status I-III
  • adult and scheduled to undergo elective forefoot surgery under regional anaesthesia

Exclusion criteria

  • patient refusal
  • ASA physical status > III
  • pregnancy
  • neuromuscular disorder
  • prior surgery in the popliteal fossa
  • coagulopathy
  • allergy to local anaesthetic drugs
  • skin infection at the site of needle insertion

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

40 participants in 2 patient groups

Levobupivacaine
Active Comparator group
Description:
0.5% levobupivacaine (0.5% Chirocaine) 30ml (150mg) will be injected once for regional anaesthesia before surgery
Treatment:
Drug: 0.5% Levobupivacaine
Xylocaine + adrenaline
Active Comparator group
Description:
2% Xylocaine with adrenaline 1:200,000 30ml (450mg) will be injected once for regional anaesthesia before surgery
Treatment:
Drug: 2% Xylocaine with adrenaline 1:200,000

Trial contacts and locations

1

Loading...

Central trial contact

Ayla Wong, RN, BN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems